作者:
Kenny, Jane R. [1]
;
Ramsden, Diane [2]
;
Buckley, David B. [3]
;
Dallas, Shannon [4]
;
Fung, Conrad [5]
;
Mohutsky, Michael [6]
;
Einolf, Heidi J. [7]
;
Chen, Liangfu [8]
;
Dekeyser, Joshua G. [9]
;
Fitzgerald, Maria [10]
;
Goosen, Theunis C. [11]
;
Siu, Y. Amy [12]
;
Walsky, Robert L. [13]
;
Zhang, George [14]
;
Tweedie, Donald [15]
;
Hariparsad, Niresh
作者单位:
Corning Life Sci, Woburn, MA USA
[1]
Vertex Pharmaceut, Boston, MA USA
[2]
Pfizer Global Res & Dev, Groton, CT USA
[3]
Merck & Co Inc, Kenilworth, NJ USA
[4]
EMD Serono R&D Inst Inc, Billerica, MA USA
[5]
Amgen Inc, Cambridge, MA USA
[6]
Sekisui XenoTech LLC, Kansas City, KS USA
[7]
Eisai, Andover, MA USA
[8]
Sanofi, Waltham, MA USA
[9]
GlaxoSmithKline, King Of Prussia, PA USA
[10]
Genentech Inc, San Francisco, CA USA
[11]
Novartis, E Hanover, NJ USA
[12]
Boehringer Ingelheim GmbH & Co KG, Ridgefield, CT USA
[13]
Janssen R&D, Spring House, PA USA
[14]
Eli Lilly & Co, Indianapolis, IN 46285 USA
[15]
发布时间
2019-03-16